Why Is Medical Device Giant Becton, Dickinson Stock Trading Lower Today?
Portfolio Pulse from Vandana Singh
Becton, Dickinson and Company (BDX) reported Q4 adjusted EPS of $3.42, slightly missing the consensus of $3.43. Sales were $5.09 billion, up 6.8% Y/Y, beating the consensus of $5.02 billion. The company declared a quarterly dividend of $0.95 per share, up 4.4% from the previous quarter. However, BDX shares are down 8.24% after the company issued lower than expected FY24 revenue and EPS guidance.
November 09, 2023 | 3:39 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Becton, Dickinson and Company's Q4 earnings slightly missed expectations, but sales beat consensus. The company declared a higher dividend but issued lower than expected FY24 guidance, causing the stock to drop 8.24%.
Becton, Dickinson and Company's Q4 earnings slightly missed expectations, which may have disappointed investors. However, sales beat consensus, indicating strong business performance. The company also declared a higher dividend, which is generally a positive signal to investors. However, the company's lower than expected FY24 guidance may have caused concerns about future performance, leading to the stock price drop.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100